The board shall adopt rules, pursuant to RSA 541-A, relative to:
I. [Repealed.]
II. The qualifications of applicants in addition to those requirements set by statute;
III. [Repealed.]
IV. How an applicant shall be examined, including:
[Paragraph IV(a) effective until September 8, 2026; see also paragraph IV(a) set out below.]
(a) The subjects to be tested;
[Paragraph IV(a) effective September 8, 2026; see also paragraph IV(a) set out above.]
(a) The subjects to be tested pursuant to RSA 318:19;
(b) Passing grade; and
(c) Disposition of examination papers;
IV-a. The standards for registering pharmacies and licensing pharmacists and the practice of pharmacy;
IV-b. The standards for licensure of research organizations;
V. [Repealed.]
VI. Ethical standards required to be met by each holder of any license issued under this chapter and how such license may be revoked for violation of these standards;
VII. [Repealed.]
VII-a. Continuing education requirements under this chapter;
VIII. [Repealed.]
IX. Standards for the inspection of licensees;
X. Registration or certification of pharmacy technicians, including:
(a) Requirements for registration or certification;
(b) The duties, functions, and standards of conduct of pharmacy technicians;
(c) Requirements for the supervision of pharmacy technicians by licensed pharmacists;
(d) Standards for denial and revocation of registration and certification;
(e) [Repealed.]
(f) Requirements for renewal of registration or certification; and
(g) Requirements for reinstatement of registration or certification.
XI. [Repealed.]
XI-a. Registration of pharmacy interns, including:
(a) Requirements for registration;
(b) The duties, functions, and standards of conduct of pharmacy interns;
(c) Requirements for the supervision of pharmacy interns by licensed pharmacists;
(d) Standards for denial and revocation of registration;
(e) [Repealed.]
(f) Requirements for renewal of registration; and
(g) Requirements for reinstatement of registration.
XI-b. [Repealed.]
XI-c. Licensure of advanced pharmacy technicians, including:
[Paragraph XI-c(a) effective until September 8, 2026; see also paragraph XI-c(a) set out below.]
(a) Requirements for licensure, including experience and education requirements.
[Paragraph XI-c(a) effective September 8, 2026; see also paragraph XI-c(a) set out above.]
(a) Requirements for licensure, including experience and education requirements. Any examination requirement for licensure shall be limited to the scope of practice, and such requirement shall be suspended if the board is unable to verify that the exam complies with board requirements.
(b) The duties, functions, and standards of conduct of licensed advanced pharmacy technicians.
(c) Standards for the supervision of licensed advanced pharmacy technicians by licensed pharmacists.
(d) Standards for denial and revocation of licensure.
(e) [Repealed.]
(f) Requirements for renewal of a license.
(g) Requirements for reinstatement of a license.
XII. Procedures for the use, documentation, security, maintenance, and monitoring of automated pharmacy systems, including the placement of automated pharmacy systems in long-term care facilities, hospices, and state or county correctional institutions, for the purposes of storage and dispensing of controlled and non-controlled prescription drugs.
XIII. Standards for contracting, implementation, and operation of central prescription processing.
XIV. The adoption of protocols and procedures for the temporary absence of a pharmacist from a pharmacy while on duty.
XV. The requirements for the use of electronic transmission prescriptions, including the contents of such order and the verification of electronic signatures.
XVI. Procedures and protocols for emergency contraception drug therapy, pursuant to RSA 318:47-e.
[Paragraph XVII effective until September 8, 2026; see also paragraph XVII set out below.]
XVII. The education and training standards and other requirements for pharmacists who, pursuant to prescriber-approved protocol:
(a) Administer prescription medications, including influenza immunizations.
(b) Engage in collaborative pharmacy practices.
[Paragraph XVII effective September 8, 2026; see also paragraph XVII set out above.]
XVII. The education and training standards and other requirements for pharmacists who, pursuant to prescriber-approved protocol, administer prescription medications outside the parameters of a collaborative pharmacy practice agreement, including influenza immunizations.
XVIII. Disclosure and confidentiality relative to the New Hampshire Rx advantage program, pursuant to RSA 161-L:3.
XIX. Dispensing hormonal contraceptives in accordance with RSA 318:47-l.
XX. The standards for licensure of drug or device distribution agents.
Source. 1981, 484:5. 1985, 324:3. 1988, 106:1; 210:3. 2000, 188:2. 2001, 282:5, 6. 2002, 281:4. 2005, 131:2; 177:128, 129. 2006, 164:4. 2007, 202:5, 6; 297:9. 2013, 105:2, eff. Aug. 23, 2013. 2015, 203:2, 3, eff. July 1, 2015. 2018, 205:3, eff. Aug. 7, 2018. 2019, 58:2, eff. July 1, 2019; 264:2, eff. Sept. 17, 2019. 2021, 197:105, II, eff. July 1, 2021. 2023, 79:305, 306, I to IV, eff. Sept. 1, 2023; 212:32, I, eff. Oct. 3, 2023. 2024, 327:128, 129, eff. July 1, 2024. 2026, 311:7, 9, 10, eff. Sept. 8, 2026.